# US 2008/0287677 A1 · Salts of Aripiprazole

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0287677 A1
- Document ID: US20080287677A1
- Status: Published application
- Kind: A1
- Application number: 11/883,125
- Filed: 2006-01-27
- Published: 2008-11-20
- Earliest claimed: 2005-01-27
- Assignees: Sandoz Ltd.
- Inventors: Johannes Ludescher; Hubert Sturm
- Web page: https://patentgrep.com/patent/US20080287677A1

## CPC

- C07D 215/227: only one oxygen atom which is attached in position 2
- A61P 25/18: Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- C07B 2200/13: Crystalline forms, e.g. polymorphs
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

The present invention relates to acid addition salts of aripiprazole, a process for preparing said acid addition salts and their use to prepare or purify aripiprazole in the form of a free base or in the form of a pharmaceutically acceptable salt.

## Claims

### Claim 1

An acid addition salt of formula
wherein Ad denotes hydroiodic acid, hydrobromic acid, oxalic acid, mesitylenesuiphonic acid, tetrafluoroboric acid, phosphoric acid or phenylphosphonic acid, or a solvate thereof.

### Claim 2 (depends on 1)

The compound according to claim 1 wherein Ad is oxalic acid.

### Claim 3 (depends on 1)

A process for preparing an acid addition salt of formula I as defined in claim 1 or a solvate thereof by reacting aripiprazole with an acid as defined by Ad in formula I of claim 1 in a inert solvent.

### Claim 4 (depends on 3)

The process according to claim 3 wherein the inert solvent is selected from the group consisting of lower alkanols, (C1-4)alkanoic acid (C1-4)alkylesters, nitrites, halogenated hydrocarbons, (C4-5)cycloalkyl ethers and mixtures thereof.

### Claim 5

A process for the production of aripiprazole or a pharmaceutically acceptable salt thereof comprising the steps of preparing and isolating an acid addition salt of aripiprazole or a solvate thereof and converting the acid addition salt or solvate thereof into aripiprazole in free form and optionally converting aripiprazole in free form into a pharmaceutically acceptable salt of aripiprazole.

### Claim 6

A process for the production of aripiprazole or a pharmaceutically acceptable salt thereof comprising the steps of
a) reacting a compound of formula
with a compound of formula
wherein X and Z are the same or different and each denote a halogen atom, or a group which is similarly to halogen groups suitable to undergo a substitution reaction, to obtain a compound of formula
wherein X denotes as in formula III,
b) reacting a compound of formula IV as obtained from step a) with a compound of formula
to obtain a compound of formula
c) isolating the compound of formula VI as obtained in step b) in the form of an acid addition salt of formula
or a solvate thereof, wherein Ac is an organic or anorganic acid, and
d) converting an acid addition salt of formula VIII as obtained in step c) into a compound of formula VI to isolate aripiprazole in free form which is optionally further converted into a pharmaceutically acceptable salt of aripiprazole.

### Claim 7 (depends on 6)

The process according to claim 6 which does not comprise any purification step of a compound of formula IV before reacting it with a compound of formula V.

### Claim 8 (depends on 6)

The process according to claim 6 wherein aripiprazole in free form is isolated with less than 0.1% (w/w) of a compound of formula VII

### Claim 9 (depends on 8)

The process according to claim 8 wherein aripiprazole in free form is isolated with less than 0.05% (w/w) of a compound of formula VII.

### Claim 10 (depends on 6)

A process for the purification of aripiprazote by preparing an acid addition salt of formula VIII as defined in claim 6, isolating said acid addition salt and converting it into aripiprazole in free form.

### Claim 11 (depends on 10)

The process according to claim 10 wherein the aripiprazole isolated in free form is an aripiprazole which is substantially pure in terms of crystalline form, by using appropriate seed crystals and containing less than 0.1% of a compound of formula VII.

### Claim 12 (depends on 5)

The acid addition salt of formula VIII as defined in claim 5 which is used in the preparation of aripiprazole.
